News · 26 weeks16+100%
2025-11-022026-04-26
Mix1090d
- Other5(50%)
- SEC Filings2(20%)
- Leadership2(20%)
- Earnings1(10%)
Latest news
25 items- PRVeradigm Receives KLAS 2026 Points of Light Award for Embedding SDOH Data in Provider EHR WorkflowsVeradigm® (OTC:MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced that it has been recognized by KLAS in the 2026 Points of Light Award program for a collaborative initiative that embedded payer-derived social determinants of health (SDOH) data directly into provider EHR workflows. The recognition, awarded as part of the KLAS K2 Collaborative, highlights a multi-organization effort involving Veradigm, a national health plan serving 27 million members, and Raleigh Durham Medical Group, an independent provider group in North Carolina. Using the Veradigm Payer Insights (VPI) platform, the initiative embedded SDOH-triggered clinical re
- PRVeradigm Doubles India-Based Employee Footprint, Adds New Managing DirectorVeradigm® India Private Limited, the India subsidiary of Veradigm (OTC:MDRX), a US-based leader in clinical and revenue cycle solutions for independent practices, today announced a major expansion of its Pune operations, doubling its office capacity and adding a new managing director. This milestone marks a significant chapter in Veradigm's growth journey, reflecting the company's continued investment in its people, its infrastructure, and its long-term vision for India. Located in one of Pune's prime business districts, the expansion is designed to support scale, inspire collaboration, and create an environment where teams can do their best work. It is a direct expression of Veradigm's f
- PRVeradigm Appoints Christian Greyenbuhl as Chief Financial OfficerVeradigm Inc. (OTC:MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced the appointment of Christian Greyenbuhl as Chief Financial Officer of the Company, effective on the later of May 11, 2026 and the first business day after Veradigm files its Annual Report on Form 10-K for its 2023 and 2024 fiscal years, or as otherwise agreed. Mr. Greyenbuhl is a seasoned operator and finance executive with more than 25 years of experience across both global public and private companies. He brings a strong track record as a general manager and operator, having served as general manager of businesses of Automatic Data Processing, Inc. ("ADP") on two occ
- SECVeradigm Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Veradigm Inc. (0001124804) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Veradigm Inc.SCHEDULE 13G/A - Veradigm Inc. (0001124804) (Subject)
- PRVeradigm Brings Patient Voice to Healthcare Research with New Real-World Data Survey SolutionVeradigm (OTC:MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced a new patient‑reported outcomes (PRO) survey capability that brings the patient voice directly into real‑world evidence generation. The new solution gives life sciences organizations timely, privacy‑preserving insights directly from patients, adding essential context to clinical and observational research. Built on Veradigm's FollowMyHealth patient engagement platform, the capability enables individuals to securely share their experiences through an account they own and manage. Patients receive project‑specific invitations through trusted channels within FollowMyHealt
- PRVeradigm to Release Business Update February 17th and Host Investor Call February 18thVeradigm® (OTC:MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that management plans to provide a business update after the close of regular stock market hours on February 17, 2026. Veradigm management plans to host an investor conference call and webcast to discuss the Company's update at 8:00 a.m. Eastern Time on February 18, 2026. Update Call Details Veradigm plans to issue a press release after the close of regular stock market hours on Tuesday, February 17, 2026. The announcement will also be available at Veradigm investor relations website. To listen to the conference call, participants may log onto the Veradigm invest
- SECAmendment: SEC Form 8-A12G/A filed by Veradigm Inc.8-A12G/A - Veradigm Inc. (0001124804) (Filer)
- SECVeradigm Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Regulation FD Disclosure8-K - Veradigm Inc. (0001124804) (Filer)
- PRVeradigm Extends Stockholder Rights PlanVeradigm® (OTC:MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced that its Board of Directors (the "Board") has approved an amendment to extend the Company's existing Stockholder Rights Plan to December 31, 2026 (the "Rights Plan"). The Board's decision to extend the Rights Plan is based on its determination that many of the underlying risks and conditions that existed upon the initial adoption of the Rights Plan will continue to be present beyond February 20, 2026. Accordingly, the Rights Plan is being extended to continue to ensure that all Veradigm stockholders have the opportunity to realize the full potential value of their in
- PRVeradigm Launches New AI Application for Powerful Revenue Cycle Insights for Independent PracticesNew AI-driven application helps Revenue Cycle Services clients gain faster, clearer visibility into financial performance Veradigm® (OTC:MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced the launch of a new AI-enabled application for Veradigm Revenue Cycle Services (RCS) clients, designed to deliver faster, deeper revenue cycle insights and strengthen the value of ongoing performance reviews for independent practices. Independent practices continue to face rising administrative complexity and financial pressure, driven by denials, payment variability, staffing constraints, and limited analytic visibility into what is driving rev
- SECVeradigm Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - Veradigm Inc. (0001124804) (Filer)
- PRVeradigm and Meperia Launch Industry-First 8-Way Match EDI Platform to Strengthen Healthcare Supply Chain IntegrityA next-generation, hospital-first EDI platform delivering transparency, accuracy, and data governance to healthcare supply chains Veradigm® (OTC:MDRX), a leading provider of healthcare data, technology, and enterprise resource planning (ERP) solutions, and Meperia (now part of Genesis Automation Healthcare), a healthcare supply chain technology company specializing in AI-powered content and spend management solutions, announced today a strategic collaboration to launch a next-generation Electronic Data Interchange (EDI) solution, purpose-built for healthcare. This new EDI platform is designed to eliminate the friction, cost, and complexity of traditional EDI platforms through an industr
- PRVeradigm Launches Enhanced Ambient Scribe CapabilitiesAI-powered solution includes multilingual support, structured diagnosis code recommendations, and clinical decision insights support tools for Veradigm EHR customers Veradigm® (OTC:MDRX), a leading provider of healthcare data and technology solutions, today announced enhancements to the artificial intelligence (AI) enhanced Ambient Scribe solution for Veradigm EHR customers. This milestone reflects Veradigm's commitment to delivering evolved AI solutions that improve clinical documentation, support clinical decision-making, and enhance patient care. Since its launch last year, Veradigm Ambient Scribe has developed into a robust AI-powered solution that passively captures patient-provide
- PRVeradigm Adds Sentara Health Plans to Veradigm Payer Insights SolutionMajor Mid-Atlantic and Southeast US Health Plan to Deploy Integrated Care Gap Alerting in Early 2026 Veradigm® (OTC:MDRX), a leading provider of healthcare data and technology solutions, announced today a new agreement with Sentara Health Plans, a prominent regional health plan, serving more than one million members. Sentara will implement the Veradigm Payer Insights software solution to deliver patient-specific care gap alerts within the electronic health record (EHR) systems used by its network providers. Veradigm Payer Insights displays critical care gap alerts directly into the provider's existing EHR workflow. This seamless integration empowers healthcare payers to support their pr
- PRVeradigm Appoints Tehsin Syed as Chief Product and Technology OfficerHealthcare IT Veteran - former AWS and Cerner senior executive - to lead and accelerate innovation across Veradigm's unique footprint Veradigm® (OTC:MDRX), a leading provider of healthcare data and technology solutions, today appoints Tehsin Syed, a healthcare technology leader with over two decades of experience, as Chief Product and Technology Officer. Syed most recently served as General Manager, AWS Health AI (Amazon Web Services). Under his leadership, the organization scaled as a growth engine, with net-new products for ambient clinical documentation, genomics, and medical imaging, and interoperability elevated to enterprise grade - capabilities trusted by providers, payers, bioph
- PRPractice Management Systems Market is Projected to Reach US$36.33 billion at CAGR of 9.3% Amid Need for Operational Efficiency & Automation | The Insight PartnersNEW YORK, Sept. 29, 2025 /PRNewswire/ -- A new in-depth report by The Insight Partners highlights Practice Management Systems market growth, driven by need for operational efficiency & automation. The comprehensive analysis dives deep into market size, emerging trends, profiles key industry players, and uncovers strategic opportunities shaping the industry landscape. With a spotlight on key market segments and applications, the Practice Management Systems report highlights the factors that drive market momentum in the years ahead. Engineered for Growth: Practice Management Systems on Rapid Ascent Practice Management Systems Market Set to Soar with Demand for Healthcare AutomationValued at U
- PRLucid Diagnostics Appoints Healthcare Industry Veteran John R. Palumbo to Board of DirectorsGrowth-focused healthcare executive brings 40 years of executive leadership experience across multiple industry sectors NEW YORK, Sept. 25, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (NASDAQ: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (NASDAQ: PAVM), today announced the appointment of accomplished healthcare executive John R. Palumbo to its Board of Directors, effective September 22, 2025. "John is a highly accomplished executive whose 40 years of healthcare leadership experience spans earl
- PRVeradigm Amends and Extends Stockholder Rights PlanVeradigm® (OTC:MDRX), a leading provider of healthcare data and technology solutions, today announced that its Board of Directors (the "Board") has approved an amendment to extend the Company's existing Stockholder Rights Plan for an additional six months (the "Rights Plan"). The Rights Plan, adopted on February 26, 2024, was due to expire at 5:00PM New York City time on August 20, 2025. Under the terms of the amendment to the Rights Plan, the scheduled expiration date of the Rights Plan has been extended to February 20, 2026. In addition, the amendment to the Rights Plan changes the triggering threshold such that the rights would become exercisable only if a person or group acquires bene
- SECVeradigm Inc. filed SEC Form 8-K: Events That Accelerate or Increase a Direct Financial Obligation8-K - Veradigm Inc. (0001124804) (Filer)
- SECVeradigm Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Veradigm Inc. (0001124804) (Filer)
- SECVeradigm Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation8-K - Veradigm Inc. (0001124804) (Filer)
- PRVeradigm to Release Business Update June 23rd and Host Investor Call June 24thVeradigm® (OTC:MDRX), a leading provider of healthcare data and technology solutions, announced today that management plans to provide a business update after the close of regular stock market hours on June 23, 2025. Veradigm management plans to host an investor conference call and webcast the Company's update at 8:00 a.m. Eastern Time on June 24, 2025. Update Call Details Veradigm plans to distribute an announcement promptly after the close of regular stock market hours on Monday, June 23, 2025. The announcement will also be available at Veradigm investor relations website. To listen to the conference call, participants may log onto the Veradigm investor relations website. Participan
- INSIDERSVP & Chief HR Officer Hammond Lisa was granted 58,140 shares, increasing direct ownership by 50% to 174,175 units (SEC Form 4)4 - Veradigm Inc. (0001124804) (Issuer)
- INSIDERSVP General Counsel Vakharia Tejal was granted 69,768 shares, increasing direct ownership by 22% to 387,476 units (SEC Form 4)4 - Veradigm Inc. (0001124804) (Issuer)
MDRX FAQ
6 questionsWhat does Veradigm Inc. do?
Allscripts Healthcare Solutions, Inc., together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates in two segments: The Core Clinical and Financial Solutions; and The Data, Analytics and Care Coordination. The Core Clinical and Financial Solutions segment provides software applications for...Where does MDRX stock trade?
Veradigm Inc. (MDRX) is listed on NASDAQ.What sector and industry is MDRX in?
Veradigm Inc. operates in the Technology sector, EDP Services industry.What are analysts saying about MDRX?
Veradigm Inc. has had 8 recent analyst actions on file. The most recent action was from Deutsche Bank: Hold with a $1000.00 price target on 2024-03-19. Recent price targets range from $1000.00 to $2600.00.What companies are similar to MDRX?
Notable peers in the same industry include NEE (NextEra Energy Inc.), PDD (PDD Holdings Inc.), INFY (Infosys Limited), DASH (DoorDash Inc.), WDAY (Workday Inc.). Compare MDRX side-by-side with any of them on Quantisnow.How can I track MDRX on Quantisnow?
Quantisnow aggregates Veradigm Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MDRX to receive live email and push alerts on every new disclosure.